- Trials with a EudraCT protocol (3,662)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (21)
3,662 result(s) found for: Adverse Event.
Displaying page 1 of 184.
EudraCT Number: 2007-002803-42 | Sponsor Protocol Number: 15.05.2007 | Start Date*: 2008-03-05 |
Sponsor Name:Univ.Clinic of Internal Medicine II, Department of Cardiology, Medical University of Vienna, Austria | ||
Full Title: Inhaled Iloprost for patients with pulmonary arterial hypertension and right heart failure:a pilot feasibility trial | ||
Medical condition: Pulmonary arterial hypertension (PAH) is associated with poor prognosis.The most common cause of death is right heart failure. The fact that right heart failure is associated with low systemic per... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-003023-10 | Sponsor Protocol Number: 03072013 | Start Date*: 2013-10-07 | |||||||||||
Sponsor Name:Department of Surgery, Herlev Hospital | |||||||||||||
Full Title: MELATOX: Pharmacodynamic evaluation of topical use of melatonin as sun protection: a randomized, double blinded, placebo controlled crossover study on healthy volunteers. | |||||||||||||
Medical condition: Adverse effects of topical use of melatonin as sun protection. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001761-11 | Sponsor Protocol Number: 300488 | Start Date*: 2015-08-31 | ||||||||||||||||
Sponsor Name:The Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital | ||||||||||||||||||
Full Title: Lymphatic dysfunction as a cause of calcium channel blocker oedema in post-menopausal women | ||||||||||||||||||
Medical condition: Calcium channel antagonist induced peripheral edema in post-menopausal women. We hypothesize that this condition is partly due to impaired lymphatic function in these patients. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-002622-75 | Sponsor Protocol Number: 2013 | Start Date*: 2013-05-21 | ||||||||||||||||
Sponsor Name:Vibeke Hjortdal | ||||||||||||||||||
Full Title: Lymphatic dysfunction as a cause of calcium channel blocker oedema | ||||||||||||||||||
Medical condition: Fluid accumulation in the leg associated with calcium channel blocker therapy. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005698-21 | Sponsor Protocol Number: EFC11570 | Start Date*: 2013-03-05 | |||||||||||
Sponsor Name:sanofi-aventis Recherche & Développement | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recentl... | |||||||||||||
Medical condition: Acute coronary syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) SE (Completed) BE (Completed) NO (Completed) EE (Completed) LT (Completed) HU (Completed) ES (Completed) CZ (Completed) LV (Completed) DE (Completed) IT (Completed) BG (Completed) FI (Completed) AT (Completed) PT (Completed) DK (Completed) NL (Completed) PL (Completed) SK (Completed) SI (Completed) HR (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-002073-26 | Sponsor Protocol Number: 1125-ECIR | Start Date*: Information not available in EudraCT | |||||||||||||||||||||
Sponsor Name:Medical Center - University of Freiburg | |||||||||||||||||||||||
Full Title: Phase 1/2 Trial to determine the safety and efficacy of Extracorporeal photopheresis as treatment for steroid-refractory immune related adverse events after immune checkpoint inhibitor therapy | |||||||||||||||||||||||
Medical condition: Immune related adverse events induced by treatment with immune checkpoint inhibitors (monoclocanl antibodies against PD-1, PD-L1 or CTLA-4) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003305-25 | Sponsor Protocol Number: CSLCT-BIO-12-83 | Start Date*: 2015-07-07 | |||||||||||
Sponsor Name:CSL Behring GmbH | |||||||||||||
Full Title: An Open-label, Multi-centre Post-marketing Study to Assess the Efficacy and Safety of Voncento® in Subjects with Von Willebrand Disease | |||||||||||||
Medical condition: Von Willebrand Disease | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) AT (Completed) IE (Completed) PL (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000789-19 | Sponsor Protocol Number: MiniCept | Start Date*: 2007-05-30 | |||||||||||||||||||||
Sponsor Name:CHU de Liège, Domaine Universitaire du Sart Tilman | |||||||||||||||||||||||
Full Title: Withdrawal of Calcineurin Inhibitors (CNIs) during administration of Mycophenolate Mofetil (MMF) in liver transplant patients suffering adverse effects from CNIs: Study of the reduction in rejectio... | |||||||||||||||||||||||
Medical condition: liver transplant patients suffering adverse effects from treatment with calcineurin inhibitors | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005273-27 | Sponsor Protocol Number: VAC52416BAC3001 | Start Date*: 2021-09-07 | ||||||||||||||||
Sponsor Name:Janssen Vaccines & Prevention B.V | ||||||||||||||||||
Full Title: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase 3 Study to Assess the Efficacy, Safety And Immunogenicity of Vaccination With ExPEC9V in the Prevention of Invasive Extraintestinal P... | ||||||||||||||||||
Medical condition: Invasive Extraintestinal Pathogenic Escherichia coli Disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Ongoing) ES (Ongoing) NL (Ongoing) IT (Prematurely Ended) CZ (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-001534-11 | Sponsor Protocol Number: GIT-PRo-2022-02 | Start Date*: 2022-10-11 | ||||||||||||||||
Sponsor Name:Grupo Gallego de Investigación en Tumores Digestivos (GITuD) | ||||||||||||||||||
Full Title: Prophylaxis of venous thromboembolic disease with LMWH (TINzaparin) in patients with metastatic colorectal cancer who start the first line of treatment. | ||||||||||||||||||
Medical condition: Metastatic colorectal cancer (mCRC), stage IV that initiates the first-line systemic treatment in the metastatic setting | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011774-15 | Sponsor Protocol Number: BASt01 | Start Date*: 2009-07-15 | |||||||||||||||||||||
Sponsor Name:Federal Highway Research Institute / Bundesanstalt für Straßenwesen (BASt) | |||||||||||||||||||||||
Full Title: Effects of opioid analgesics on driving ability of pain patients [Untersuchung zur Fahrsicherheit von Schmerzpatienten] | |||||||||||||||||||||||
Medical condition: patients suffering from chronic non-cancer pain responsive to opioid analgesics under already existing long-term treatment | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) NL (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-000487-15 | Sponsor Protocol Number: CLSYN.1702 | Start Date*: 2018-12-21 | |||||||||||
Sponsor Name:Hamilton Health Sciences Corporation through its Population Health Research Institute | |||||||||||||
Full Title: CLEAR SYNERGY (OASIS 9) A 2x2 factorial randomized controlled trial of CoLchicine and spironolactonE in patients with ST elevation myocARdial infarction/SYNERGY Stent Registry – Organization to Ass... | |||||||||||||
Medical condition: ST segment Elevation Myocardial Infarction (STEMI) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) FI (Ongoing) CZ (Ongoing) NL (Ongoing) HU (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-003572-16 | Sponsor Protocol Number: TAK-633-3008 | Start Date*: 2022-12-06 | |||||||||||
Sponsor Name:Takeda | |||||||||||||
Full Title: A Phase 3, Open-label Safety Study of Teduglutide in Japanese Pediatric Patients With Short Bowel Syndrome Who are Dependent on Parenteral Support, Aged 4 Months of Corrected Gestational Age or Old... | |||||||||||||
Medical condition: Short Bowel Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011222-34 | Sponsor Protocol Number: SYR-322_402 | Start Date*: 2009-11-09 | ||||||||||||||||
Sponsor Name:Takeda Global Research & Development Centre (Europe) Ltd. | ||||||||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment with Alogliptin in Addition to Standard of Care in Subjects with Type 2 Di... | ||||||||||||||||||
Medical condition: Type 2 diabetes mellitus (T2DM) and acute coronary syndrome (ACS) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) HU (Completed) ES (Completed) CZ (Completed) SE (Completed) DE (Completed) FR (Completed) DK (Completed) IT (Completed) BG (Completed) LV (Completed) FI (Completed) LT (Completed) AT (Completed) SK (Completed) PT (Completed) GB (Completed) GR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-003253-21 | Sponsor Protocol Number: 2013-99 | Start Date*: 2018-05-30 | |||||||||||
Sponsor Name:Universitätsklinikum Münster | |||||||||||||
Full Title: B-NHL 2013 - Treatment protocol of the NHL-BFM and the NOPHO study groups for mature aggressive B-cell lymphoma and leukemia in children and adolescents | |||||||||||||
Medical condition: mature aggressive B-cell lymphoma and leukemia in children and adolescents | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Ongoing) DE (Trial now transitioned) SE (Ongoing) FI (Trial now transitioned) DK (Trial now transitioned) AT (Trial now transitioned) NO (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-005184-13 | Sponsor Protocol Number: 50129 | Start Date*: 2017-11-29 |
Sponsor Name:MEDIOLANUM FARMACEUTICI S.P.A. | ||
Full Title: METRO STUDY - MESOGLYCAN VERSUS PLACEBO IN SECONDARY PREVENTION OF SURFACE VEIN THROMBOSIS | ||
Medical condition: patients with SVT of the lower limbs that have completed the acute phase treatment cycle | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-003076-14 | Sponsor Protocol Number: ANT-007 | Start Date*: 2022-05-10 |
Sponsor Name:Anthos Therapeutics | ||
Full Title: A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to apixaban on venous thromboembolism (VTE) recurrence and bleeding in ... | ||
Medical condition: venous thromboembolism (VTE) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LV (Ongoing) NO (Ongoing) IE (Ongoing) ES (Ongoing) NL (Ongoing) IT (Ongoing) HU (Ongoing) SE (Ongoing) AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001626-22 | Sponsor Protocol Number: RML-TB | Start Date*: 2022-03-28 |
Sponsor Name:Vall d'Hebron Institute of Research | ||
Full Title: A Multicentre Controlled Open Randomized Clinical Trial to evaluate the efficacy and safety profile of an anti-TB drug combination based on High Dose Rifampicin, High Dose Moxifloxacin and Linezoli... | ||
Medical condition: Smear-positive rifampicin-sensitive pulmonary Tuberculosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-001117-86 | Sponsor Protocol Number: 16/0340 | Start Date*: 2017-07-25 |
Sponsor Name:University College London | ||
Full Title: A phase IV, prospective, randomised single-blind UK multicentre non-inferiority trial of low-dose versus standard dose rituximab for prevention of relapses in acquired TTP | ||
Medical condition: Acquired thrombotic thrombocytopenic purpura | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2021-003085-12 | Sponsor Protocol Number: ANT-008 | Start Date*: 2022-05-10 |
Sponsor Name:Anthos Therapeutics | ||
Full Title: A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to dalteparin on venous thromboembolism (VTE) recurrence and bleeding i... | ||
Medical condition: venous thromboembolism (VTE) in patients with gastrointestinal/genitourinary cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LV (Ongoing) NO (Ongoing) IE (Ongoing) ES (Ongoing) HU (Ongoing) IT (Ongoing) NL (Ongoing) SE (Ongoing) AT (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.